Syngene International Q2: Profit Shrinks & Margins Narrow, CEO Jonathan Hunt On Growth Outlook

Syngene International's Q2 saw profit shrink and margins narrow. Jonathan Hunt, MD & CEO, provided insights, noting that new biologics manufacturing capacity is set to launch in H2FY25. He anticipates high-single digit to low double-digit growth for FY25, alongside expanding discovery services in Bengaluru and Hyderabad. Revenue growth is expected to mirror this range, while PAT growth is projected to remain in the single digits.

#syngene #sharemarket #stockmarket
--------------------------------------------------------------------------------------------------------------------------------------------------
Click here to subscribe to our NDTV World YouTube Channel -    / @ndtvworld  

For more videos subscribe to our channel:    / @ndtvprofitindia  
Visit NDTV Profit for more news: https://www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.ndtvprofit.com/research-r...

Follow NDTV Profit here
Twitter:   / ndtvprofitindia   ,   / ndtvprofit  
LinkedIn:   / ndtvprofit  
Instagram:   / ndtvprofit  
Facebook:   / ndtvprofit